Malaysia MDA Tightens Oversight of Medical Device Procurement with MDA Circular No. 1/2026

On March 5, 2026, the Medical Device Authority (MDA) of Malaysia announced the implementation of “Medical Device Authority (PBPP) Circular No. 1/2026,” which came into full effect on January 28, 2026.

The circular introduces clearer regulatory expectations for the procurement of medical devices by healthcare facility institutions, reinforcing compliance obligations under the “Medical Device Act 2012 (Act 737).” In particular, it clarifies that companies supplying devices through tender-based procurement processes are performing regulated market activities and must meet the same licensing and quality system requirements applied to medical device distributors.

For international manufacturers supplying Malaysia through local partners, the circular signals increased regulatory scrutiny over how devices enter institutional supply chains.

Tender Participation Recognized as Market Placement Activity

According to the MDA, any company or supplier representative that participates in and wins a medical device procurement tender is considered an “establishment” under the “Medical Device Act 2012 (Act 737).” Supplying products through a procurement contract is therefore treated as placing a medical device on the Malaysian market.

This interpretation formally brings procurement activities within Malaysia’s medical device regulatory framework. In practice, it means that companies cannot supply devices through tenders unless they meet the same compliance obligations that apply to licensed distributors.

For foreign manufacturers, this clarification reinforces the importance of ensuring that local partners involved in tender participation hold the necessary regulatory authorizations.

Licensing and Quality System Requirements for Tender Suppliers

Organizations participating in procurement tenders must:

• Hold a valid medical device establishment licence to conduct distribution activities in Malaysia
• Implement a Quality Management System (QMS) aligned with Good Distribution Practice for Medical Devices (GDPMD)
• Fulfil post-market surveillance obligations, including Incident reporting to the MDA, complaint investigation, and field corrective actions or product recalls where necessary.

These requirements ensure that devices supplied through government or institutional procurement channels remain subject to the same regulatory oversight applied to other commercial distribution pathways.

Procurement Verification Responsibilities for Healthcare Institutions

In addition to clarifying obligations for suppliers, healthcare institutions involved in procurement bear verification responsibilities.

Public and private healthcare facilities must confirm that tender participants meet regulatory requirements before procurement contracts are finalized. This step adds an additional layer of compliance oversight within the procurement process.

Healthcare institutions must obtain the following documentation from tenderers:

• A valid medical device establishment license as a distributor
• A medical device registration certificate for the product being supplied
• A letter of appointment as distributor issued by the Authorized Representative (AR) or the original establishment

These verification measures aim to prevent unlicensed entities from supplying medical devices through institutional procurement channels.

Transitional Exemptions for Existing Tenders

To avoid disruption to ongoing procurement contracts and medical device supply, the MDA has introduced temporary exemptions for certain tender participants.

The exemption applies to medical device tenderers that fall into one of the following categories:

• Category I: Suppliers currently providing medical devices under tenders awarded before January 28, 2026
• Category II: Tenderers that received a Letter of Acceptance (LOA) or tender award before January 28, 2026
• Category III: Companies that participated in tender processes initiated through advertisements issued before January 28, 2026

These exemptions remain valid until either the expiration of the existing contract or the completion of the relevant tender process. After this transitional period ends, all suppliers participating in procurement activities will be required to comply fully with the regulatory requirements introduced under the circular.

Regulatory Implications for Manufacturers and Distributors

Foreign manufacturers, authorized representatives, and distributors participating in Malaysian tenders should review their regulatory strategies to confirm that:

• Local partners involved in procurement activities hold valid MDA establishment licenses
• Distribution operations comply with GDPMD requirements
• Post-market surveillance systems support incident reporting and corrective actions

Final Thoughts

The implementation of “Medical Device Authority (PBPP) Circular No. 1/2026” strengthens Malaysia’s regulatory oversight of medical device procurement activities. By formally recognizing tender supply as a market placement activity, the MDA ensures that procurement channels are subject to the same regulatory controls applied to other distribution pathways.

This clarification has immediate implications for companies supplying medical devices through institutional tenders. Manufacturers must now ensure that tender participants operate as properly licensed establishments, maintain GDPMD-compliant distribution systems, and are prepared to meet Malaysia’s post-market surveillance requirements.

To navigate these requirements, many foreign manufacturers rely on experienced regulatory partners. Cisema supports international medical device companies by acting as an independent Authorized Representative and license holder in Malaysia, enabling compliant market access while preserving the flexibility to work with multiple distributors.

For foreign manufacturers seeking to participate in Malaysian procurement tenders, contact Cisema for expert regulatory support.

Further Information

• Explore Cisema’s services for Medical Device Registration in Malaysia.
• Read our article Medical Device Registration in Malaysia: A Practical Guide for Foreign Manufacturers with Latest Timelines, Fees & Tips.

References

“Implementation of Medical Device Authority (PBPP) Circular No. 1 of 2026.”